Actemra 160mg, a drug known scientifically as tocilizumab, functions as a potent pharmaceutical agent primarily used for the treatment of rheumatoid arthritis. This effective agent operates by blocking the activity of interleukin-6 (IL-6), a communication protein crucial in the inflammatory process. Additionally, Actemra exhibits effectiveness in